Observational Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jun 26, 2021; 9(18): 4644-4653
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4644
Table 3 Univariate analysis of risk factors associated with delayed gastric emptying after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Variable
n
DGE
X2
P value
Yes
No
Age (yr)2.6970.101
≥ 70963
< 70682246
BMI (kg/m2)5.0590.025
≥ 2335827
< 23422022
Pelvic surgery history4.4980.034
Yes621943
No1596
Comorbidity (DM/HBP)2.8020.094
Yes241212
No531637
History of chemotherapy4.3340.037
≥ 7 cycles34826
< 7 cycles432023
CA-125 level0.9900.320
Normal (< 35 U/mL)12210
Elevated (≥ 35 U/mL)652540
Pleural effusion before surgery0.3590.549
Yes19811
No582038
PCI1.9670.161
≥ 10522230
< 1014212
Diaphragmatic invasion0.7170.397
Yes231013
No541836
Perigastric and gastric dissection0.6480.421
Yes1367
No642242
Operation time4.8270.047
≥ 7 h652738
7 h12111
Intraoperative hemorrhage7.1120.008
≥ 800 mL291613
< 800 mL481236
Anastomosis3.6340.057
Yes532330
No24519
Number of organs removed2.4950.114
≥ 4271314
< 4501535
Pleural effusion after surgery3.6670.056
Yes442024
No33825